The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.
SMJ // Article
Editorial
The Impact of Diabetes Mellitus On Endothelial Dysfunction
Abstract
Coronary artery, cerebrovascular and peripheral vascular disease (PVD) are the principal causes of morbidity and mortality in type 2 diabetes mellitus (DM).1 The augmented risk of macrovascular disease in DM is partly due to the considerably higher incidence of conventional cardiovascular risk factors, such as hypertension, obesity and dyslipidemia.2 However, we should not forget that the pathophysiology of complications in the setting of DM is multifactorial, and in addition to the “conventional” risk factors, there are many other closely inter-related processes that develop in parallel, progress with time, and are strongly and independently associated with the risk of death on a background of DM.1,3This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
References
1. Varughese GI, Tomson J, Lip GY. Type 2 diabetes mellitus: a cardiovascular perspective. Int J Clin Pract 2005;59:798–816.
2. Varughese GI, Patel JV, Lip GY. Blood pressure control in the setting of diabetes mellitus: new targets, new hope for improvement? J Hum Hypertens 2006;20:635–637.
3. Varughese GI, Lip GY. Hypertension in patients with type-II diabetes: relation to urinary albumin excretion, endothelial function and inflammation. J Hum Hypertens 2005;19:421–424.
4. Wachtel MS, Frezza EE. Local biological factors that influence amputations in diabetic patients.South Med J 2006;100:158–161.
5. Lim HS, Chong AY, Freestone B, et al. The effect of multi-factorial intervention on plasma von Willebrand factor, soluble E-selectin and tissue factor in diabetes mellitus: implications for atherosclerotic vascular disease. Diabet Med 2005;22:249–255.
6. Lim HS, Blann AD, Chong AY, et al. Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention.Diabetes Care 2004;27:2918–2924.
7. McClung JA, Naseer N, Saleem M, et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA(1)c. Diabetologia 2005;48:345–350.
8. Fadini GP, Sartore S, Albiero M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006;26:2140–2146.
9. Fadini GP, Miorin M, Facco M, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005;45:1449–1457.
10. Tsui JC, Dashwood MR. A role for endothelin-1 in peripheral vascular disease. Curr Vasc Pharmacol 2005;3:325–332.
11. Varughese GI, Patel JV, Lip GY, et al. Novel concepts of statin therapy for cardiovascular risk reduction in hypertension. Curr Pharm Des 2006;12:1593–1609.
12. Varughese GI, Scarpello JH. The role of deranged glucose metabolism. Arch Intern Med 2006;166:1784–1785.
13. Avogaro A, Fadini GP, Gallo A, et al. Endothelial dysfunction in type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2006;16 (Suppl 1):S39–45.
14. Varughese GI, Patel JV, Tomson J, et al. The prothrombotic risk of diabetes mellitus in atrial fibrillation and heart failure. J Thromb Haemost 2005;3:2811–2813.
